To prevent hepatitis B virus (HBV) reactivation‐related hepatitis, we examined the clinical usefulness of a highly sensitive HB core‐related antigen (iTACT‐HBcrAg) assay in patients with resolved HBV infection after nucleos(t)ide… Click to show full abstract
To prevent hepatitis B virus (HBV) reactivation‐related hepatitis, we examined the clinical usefulness of a highly sensitive HB core‐related antigen (iTACT‐HBcrAg) assay in patients with resolved HBV infection after nucleos(t)ide analog (NA) treatment for HBV reactivation.
               
Click one of the above tabs to view related content.